dc.contributor.author |
Mavragani, CP |
en |
dc.contributor.author |
Voulgarelis, M |
en |
dc.date.accessioned |
2014-03-01T01:56:31Z |
|
dc.date.available |
2014-03-01T01:56:31Z |
|
dc.date.issued |
2007 |
en |
dc.identifier.issn |
0770-3198 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/28144 |
|
dc.subject |
c-ANCA |
en |
dc.subject |
retroperitoneal fibrosis |
en |
dc.subject |
vasculitis |
en |
dc.subject.classification |
Rheumatology |
en |
dc.subject.other |
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES |
en |
dc.subject.other |
IDIOPATHIC RETROPERITONEAL |
en |
dc.subject.other |
CHRONIC PERIAORTITIS |
en |
dc.subject.other |
VASCULITIS |
en |
dc.subject.other |
DISEASE |
en |
dc.title |
Retroperitoneal fibrosis and c-ANCA positivity |
en |
heal.type |
journalArticle |
en |
heal.language |
English |
en |
heal.publicationDate |
2007 |
en |
heal.abstract |
Retroperitoneal fibrosis (RPF) is an uncommon collagen vascular disease characterized by a chronic nonspecific inflammation of the retroperitoneum, which can entrap and obstruct retroperitoneal structures. Although obscure, an autoimmune-mediated or vasculitic etiology has been hypothesized. In the current report, a case of RPF associated with the presence of antibodies against proteinase III, which responded effectively to immunosuppressive therapy, is presented. |
en |
heal.publisher |
SPRINGER |
en |
heal.journalName |
CLINICAL RHEUMATOLOGY |
en |
dc.identifier.isi |
ISI:000243032100027 |
en |
dc.identifier.volume |
26 |
en |
dc.identifier.issue |
1 |
en |
dc.identifier.spage |
115 |
en |
dc.identifier.epage |
116 |
en |